(Q69737532)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

J H Lewis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

R C Ranard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

A Caruso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

L K Jackson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

F Mullick

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

K G Ishak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

L B Seeff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

H J Zimmerman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

language of work or name

English

0 references

publication date

1 May 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

679-685

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Adverse reactions during treatment with amiodarone hydrochloride

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Side effects and complications of amiodarone therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Long-term tolerance of amiodarone treatment for cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Pneumonitis after amiodarone therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Side effects and possible contraindications of amiodarone use.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Neuropathy and fatal hepatitis in a patient receiving amiodarone

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Fatal hepatic failure and encephalopathy associated with amiodarone therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone hepatotoxicity. A clinicopathologic study of five patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Chronic liver disease after low daily doses of amiodarone. Report of three cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Long-term hepatic tolerance of amiodarone in the clinic

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone hepatotoxicity simulating alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Clinical and morphologic effects of amiodarone on the liver.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Probable early acute hepatitis with parenteral amiodarone

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

A Peculiar Cutaneous Pigmentation from Cordarone

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone keratopathy: drug-induced lipid storage disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Frequent neurologic toxicity associated with amiodarone therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodaron neuropathy: further arguments for human drug-induced neurolipidosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Increased hepatic density and phospholipidosis due to amiodarone

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Long-term amiodarone therapy: a cause of increased hepatic attenuation on CT

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Abnormal abdominal computerized tomography with amiodarone therapy and clinical significance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Value of hepatic computerized tomographic scanning during amiodarone therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Chloroquine treatment does not cause phospholipid storage by depleting rat liver lysosomes of acid phospholipase A.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone-induced phospholipidosis in rat alveolar macrophages

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone--an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone-induced hepatic phospholipidosis: Correlation of morphological and biochemical findings in an animal model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Amiodarone pulmonary toxicity: functional and ultrastructural evaluation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Effect of phenobarbitone on the pharmacokinetics and tissue levels of amiodarone in the rat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Computed Tomography in the Diagnosis of Disorders of Excessive Iron Storage of the Liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Computed tomography of the liver and kidneys in glycogen storage disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840090504

7 January 2021

Identifiers

DOI

10.1002/HEP.1840090504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785079%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference